Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (661-670 of 808) with videos related to

Pageof 81
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2015
The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutritionJoseph F Pierre, Joshua C Neuman, Allison L Brill, et al.
Blood|July 12, 2019
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphomaAnja Mottok, Stacy S Hung, Elizabeth A Chavez, et al.
Blood Advances|August 26, 2021
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approachPhoebe T M Cheng, Diego Villa, R Petter Tonseth, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 23, 2019
Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral HeterogeneityMichael D Nissen, Manabu Kusakabe, Xuehai Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphomaAnas Younes, Ajay K Gopal, Scott E Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)Leo I Gordon, Fangxin Hong, Richard I Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Revised response criteria for malignant lymphomaBruce D Cheson, Beate Pfistner, Malik E Juweid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphomaDiego Villa, Anupkumar George, John F Seymour, et al.
Blood Advances|July 10, 2019
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter studyAllison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, et al.
Leukemia & Lymphoma|December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
Pageof 81

Showing results (661-670 of 808) with videos related to

Sort By:
Pageof 81
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2015
The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutritionJoseph F Pierre, Joshua C Neuman, Allison L Brill, et al.
Blood|July 12, 2019
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphomaAnja Mottok, Stacy S Hung, Elizabeth A Chavez, et al.
Blood Advances|August 26, 2021
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approachPhoebe T M Cheng, Diego Villa, R Petter Tonseth, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 23, 2019
Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral HeterogeneityMichael D Nissen, Manabu Kusakabe, Xuehai Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphomaAnas Younes, Ajay K Gopal, Scott E Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)Leo I Gordon, Fangxin Hong, Richard I Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Revised response criteria for malignant lymphomaBruce D Cheson, Beate Pfistner, Malik E Juweid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphomaDiego Villa, Anupkumar George, John F Seymour, et al.
Blood Advances|July 10, 2019
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter studyAllison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, et al.
Leukemia & Lymphoma|December 8, 2010
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)Christopher P Venner, Joseph M Connors, Heather J Sutherland, et al.
Pageof 81